FDA Approves New Hepatitis C Drug That Could Save Millions of Lives
FDA approves new hepatitis C drug that could save millions of lives
Dr. Donald Jensen of the University of Chicago said he's optimistic that new drugs like Sovaldi will increase treatment of the disease, which is blamed for 15,000 U.S. deaths per year. “I'm hoping that these new, less toxic… Continue reading
New Drug, Study Method Show Breast Cancer Promise
New drug, study method show breast cancer promise
SAN ANTONIO A novel way to speed the testing of cancer drugs and quickly separate winners from duds has yielded its first big result: an experimental medicine that shows promise against a hard-to-treat form of breast cancer. The method … Each… Continue reading
County Employees May Face Testing
County employees may face testing
… drug and alcohol testing policy in 2012. Prior to the law change, if the county instituted a drug and alcohol testing policy, it would also be financially responsible for additional services such as potentially costly in or out patient drug … Read more on… Continue reading
A Better Treatment for Hepatitis C
A Better Treatment for Hepatitis C
Pharmasset did not have a single major drug on the market, but the company had developed a drug called sofosbuvir, which promised to do for hepatitis C what protease inhibitors did for H.I.V. in the mid-nineties: transform a hard-to-treat illness into … Read more… Continue reading
Harford County, Maryland State Police Formally Unveil Drug Drop Box
Harford County, Maryland State Police formally unveil drug drop box
Police said the inspiration for the box came after the county received 1,700 pounds of drugs during national Prescription Drug Take Back Day last month. The county says installing box will help shut down this gateway to prescription drug abuse… Continue reading
Biozone Pharmaceuticals Announces Executed Letter of Intent to Merge With …
Biozone Pharmaceuticals Announces Executed Letter of Intent to Merge With …
We believe in our ability to discover oral, once-a-day, broad-spectrum antiviral drug candidates targeting the polymerase enzyme of the Hepatitis C virus. Our other first-in-class therapeutic programs have the potential to be billion dollar … Read more on MarketWatch… Continue reading